Skip to main content
Top
Published in: BMC Public Health 1/2024

Open Access 01-12-2024 | COVID-19 Vaccination | Research

COVID-19 vaccine hesitancy: assessing the prevalence, predictors, and effectiveness of a community pharmacy based counseling intervention

Authors: Joshua Kiptoo, John Isiiko, Tadele Mekuriya Yadesa, Tumugumye Rhodah, Paul E. Alele, Edgar Mugema Mulogo

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Background

Coronavirus disease (COVID-19) vaccine hesitancy is a global challenge. In low- and middle-income countries (LMICs), the problem has persisted despite vaccine availability and decreasing infections. In Uganda, there is still limited information on the extent and predictors of vaccine hesitancy. This study sought to assess the prevalence and predictors of COVID-19 vaccine hesitancy, and the effectiveness of an intervention that involved community pharmacy counseling in combating COVID-19 vaccine hesitancy.

Methods

A total of 394 participants were enrolled in a 4-week prospective cohort interventional study. The study was conducted across eight community pharmacies in Mbarara City, between 9:00 AM and 5:00 PM daily. The study personnel ascertained the vaccination status of all clients seeking community pharmacy services. All unvaccinated clients were consecutively assessed for eligibility, and eligible clients were systematically enrolled after receiving the community pharmacy services for which they requested. The study intervention involved structured participant counseling (within the pharmacy premise), follow-up short message service (weekly), and telephone calls (bi-weekly). Only participants who did not accept to receive the COVID-19 vaccine despite counseling were followed up for four weeks, or until they accepted to receive a COVID-19 vaccine. The effectiveness of the community pharmacy counseling intervention was determined as an increase in COVID-19 vaccine acceptance, and desirable attitudinal change towards COVID-19 disease, vaccination exercise, and vaccines. Descriptive analysis was used to summarize data, and multivariate analysis was used to determine the predictors of COVID-19 vaccine hesitancy. A p-value < 0.05 was considered statistically significant.

Results

Out of 394 participants, 221 (56%) were hesitant to receive a COVID-19 vaccine. Participants expressed several reasons (mean 2±1) for COVID-19 vaccine hesitancy, mostly concerning vaccine safety (N=160, 47.3%). The overall COVID-19 vaccine acceptance rate increased by 25.4 percent points (43.9 – 69.3 percent points) after the study intervention. Age, religion, level of education, distance from the nearest public health facility, having a friend/family diagnosed with COVID-19, and personal suspicion of contracting COVID-19 were significant predictors of COVID-19 vaccine hesitancy.

Conclusion

COVID-19 vaccine hesitancy is a big challenge in Uganda. A mix of sociodemographic and COVID-19 vaccine perceptions are the key predictors of COVID-19 vaccine hesitancy. Although COVID-19 vaccines were not available at the time of the study, this study found that structured counseling interventions can improve COVID-19 vaccine acceptance rates. Larger prospective studies should evaluate the effectiveness of similar interventions in community pharmacies and other healthcare settings.
Literature
1.
go back to reference Kandel N, Chungong S, Omaar A, Xing J. Health security capacities in the context of COVID-19 outbreak: an analysis of International Health Regulations annual report data from 182 countries. Lancet. 2020;395(10229):1047–53.PubMedPubMedCentralCrossRef Kandel N, Chungong S, Omaar A, Xing J. Health security capacities in the context of COVID-19 outbreak: an analysis of International Health Regulations annual report data from 182 countries. Lancet. 2020;395(10229):1047–53.PubMedPubMedCentralCrossRef
2.
go back to reference Tessema GA, Kinfu Y, Dachew BA, Tesema AG, Assefa Y, Alene KA, et al. The COVID-19 pandemic and healthcare systems in Africa: a scoping review of preparedness, impact and response. BMJ Global Health. 2021;6(12):e007179.PubMedCrossRef Tessema GA, Kinfu Y, Dachew BA, Tesema AG, Assefa Y, Alene KA, et al. The COVID-19 pandemic and healthcare systems in Africa: a scoping review of preparedness, impact and response. BMJ Global Health. 2021;6(12):e007179.PubMedCrossRef
3.
go back to reference Levin AT, Owusu-Boaitey N, Pugh S, Fosdick BK, Zwi AB, Malani A, et al. Assessing the burden of COVID-19 in developing countries: systematic review, meta-analysis and public policy implications. BMJ Global Health. 2022;7(5):e008477.PubMedCrossRef Levin AT, Owusu-Boaitey N, Pugh S, Fosdick BK, Zwi AB, Malani A, et al. Assessing the burden of COVID-19 in developing countries: systematic review, meta-analysis and public policy implications. BMJ Global Health. 2022;7(5):e008477.PubMedCrossRef
4.
go back to reference Lau H, Khosrawipour V, Kocbach P, Mikolajczyk A, Schubert J, Bania J, et al. The positive impact of lockdown in Wuhan on containing the COVID-19 outbreak in China. J Travel Med. 2020;27(3):1–7.CrossRef Lau H, Khosrawipour V, Kocbach P, Mikolajczyk A, Schubert J, Bania J, et al. The positive impact of lockdown in Wuhan on containing the COVID-19 outbreak in China. J Travel Med. 2020;27(3):1–7.CrossRef
6.
go back to reference Ghosal S, Bhattacharyya R, Majumder M. Impact of complete lockdown on total infection and death rates: a hierarchical cluster analysis. Diabetes Metab Syndr. 2020;14(4):707–11.PubMedPubMedCentralCrossRef Ghosal S, Bhattacharyya R, Majumder M. Impact of complete lockdown on total infection and death rates: a hierarchical cluster analysis. Diabetes Metab Syndr. 2020;14(4):707–11.PubMedPubMedCentralCrossRef
7.
go back to reference Yu Z, Razzaq A, Rehman A, Shah A, Jameel K, Mor RS. Disruption in global supply chain and socio-economic shocks: a lesson from COVID-19 for sustainable production and consumption. Oper Manag Res. 2021;15:233–48.CrossRef Yu Z, Razzaq A, Rehman A, Shah A, Jameel K, Mor RS. Disruption in global supply chain and socio-economic shocks: a lesson from COVID-19 for sustainable production and consumption. Oper Manag Res. 2021;15:233–48.CrossRef
8.
go back to reference Matovu JK, Kabwama SN, Ssekamatte T, Ssenkusu J, Wanyenze RK. COVID-19 awareness, adoption of COVID-19 preventive measures, and effects of COVID-19 lockdown among adolescent boys and young men in Kampala Uganda. J Community Health. 2021;46(4):842–53.PubMedPubMedCentralCrossRef Matovu JK, Kabwama SN, Ssekamatte T, Ssenkusu J, Wanyenze RK. COVID-19 awareness, adoption of COVID-19 preventive measures, and effects of COVID-19 lockdown among adolescent boys and young men in Kampala Uganda. J Community Health. 2021;46(4):842–53.PubMedPubMedCentralCrossRef
9.
go back to reference Kansiime MK, Tambo JA, Mugambi I, Bundi M, Kara A, Owuor C. COVID-19 implications on household income and food security in Kenya and Uganda: Findings from a rapid assessment. World Dev. 2021;137:105199.PubMedCrossRef Kansiime MK, Tambo JA, Mugambi I, Bundi M, Kara A, Owuor C. COVID-19 implications on household income and food security in Kenya and Uganda: Findings from a rapid assessment. World Dev. 2021;137:105199.PubMedCrossRef
10.
go back to reference Cao C, Wang L, Fang R, Liu P, Bi Y, Luo S, et al. Anxiety, depression, and PTSD symptoms among high school students in china in response to the COVID-19 pandemic and lockdown. J Affect Disord. 2022;296:126–9.PubMedCrossRef Cao C, Wang L, Fang R, Liu P, Bi Y, Luo S, et al. Anxiety, depression, and PTSD symptoms among high school students in china in response to the COVID-19 pandemic and lockdown. J Affect Disord. 2022;296:126–9.PubMedCrossRef
11.
go back to reference Batteux E, Mills F, Jones LF, Symons C, Weston D. The Effectiveness of Interventions for Increasing COVID-19 Vaccine Uptake: A Systematic Review. Vaccines. 2022;10(3):386.PubMedPubMedCentralCrossRef Batteux E, Mills F, Jones LF, Symons C, Weston D. The Effectiveness of Interventions for Increasing COVID-19 Vaccine Uptake: A Systematic Review. Vaccines. 2022;10(3):386.PubMedPubMedCentralCrossRef
12.
go back to reference Derevyankina E, Yankovskaya D. The impact of Covid-19 on supply chain management and global economy development. 2021;9(4):765–74. Derevyankina E, Yankovskaya D. The impact of Covid-19 on supply chain management and global economy development. 2021;9(4):765–74.
13.
go back to reference Bante A, Mersha A, Tesfaye A, Tsegaye B, Shibiru S, Ayele G, et al. Adherence with COVID-19 preventive measures and associated factors among residents of Dirashe District Southern Ethiopia. Patient Prefer Adher. 2021;15:237–49.CrossRef Bante A, Mersha A, Tesfaye A, Tsegaye B, Shibiru S, Ayele G, et al. Adherence with COVID-19 preventive measures and associated factors among residents of Dirashe District Southern Ethiopia. Patient Prefer Adher. 2021;15:237–49.CrossRef
14.
go back to reference Gandhi PA, Rehman T, Ilanchoorian D, Kathirvel S. Community Preparedness and Practices for Prevention and Control of COVID-19 (COP-COVID): An Assessment from Rural Northern India. Disaster Med Public Health Prepared. 2023;17:e29.CrossRef Gandhi PA, Rehman T, Ilanchoorian D, Kathirvel S. Community Preparedness and Practices for Prevention and Control of COVID-19 (COP-COVID): An Assessment from Rural Northern India. Disaster Med Public Health Prepared. 2023;17:e29.CrossRef
15.
go back to reference Tadesse T, Alemu T, Amogne G, Endazenaw G, Mamo E, Predictors of coronavirus disease,. (COVID-19) prevention practices using health belief model among employees in Addis Ababa, Ethiopia, 2020. Infect Drug Resist. 2019;2020:3751–61. Tadesse T, Alemu T, Amogne G, Endazenaw G, Mamo E, Predictors of coronavirus disease,. (COVID-19) prevention practices using health belief model among employees in Addis Ababa, Ethiopia, 2020. Infect Drug Resist. 2019;2020:3751–61.
16.
go back to reference Tatar M, Shoorekchali JM, Faraji MR, Wilson FA. International COVID-19 vaccine inequality amid the pandemic: Perpetuating a global crisis? J Global Health. 2021;11:03086.CrossRef Tatar M, Shoorekchali JM, Faraji MR, Wilson FA. International COVID-19 vaccine inequality amid the pandemic: Perpetuating a global crisis? J Global Health. 2021;11:03086.CrossRef
17.
go back to reference Altindis E. Inequitable COVID-19 vaccine distribution and the intellectual property rights prolong the pandemic. Expert Rev Vaccines. 2022;21(4):427–30.PubMedCrossRef Altindis E. Inequitable COVID-19 vaccine distribution and the intellectual property rights prolong the pandemic. Expert Rev Vaccines. 2022;21(4):427–30.PubMedCrossRef
19.
21.
go back to reference WHO. World Health Organization. Ten health issues WHO will tackle this year. 2019. WHO. World Health Organization. Ten health issues WHO will tackle this year. 2019.
22.
go back to reference Eccleston-Turner M, Upton H. International collaboration to ensure equitable access to vaccines for COVID-19: the ACT-Accelerator and the COVAX facility. The Milbank Quarterly. 2021;99(2):426–49.PubMedPubMedCentralCrossRef Eccleston-Turner M, Upton H. International collaboration to ensure equitable access to vaccines for COVID-19: the ACT-Accelerator and the COVAX facility. The Milbank Quarterly. 2021;99(2):426–49.PubMedPubMedCentralCrossRef
23.
go back to reference WHO. Accelerating COVID-19 Vaccine Deployment. 2022. WHO. Accelerating COVID-19 Vaccine Deployment. 2022.
24.
go back to reference Wong RS. COVID-19 vaccines and herd immunity: Perspectives, challenges and prospects. Malays J Pathol. 2021;43(2):203–17.PubMed Wong RS. COVID-19 vaccines and herd immunity: Perspectives, challenges and prospects. Malays J Pathol. 2021;43(2):203–17.PubMed
25.
go back to reference Larson HJ, Jarrett C, Eckersberger E, Smith DM, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007–2012. Vaccine. 2014;32(19):2150–9.PubMedCrossRef Larson HJ, Jarrett C, Eckersberger E, Smith DM, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007–2012. Vaccine. 2014;32(19):2150–9.PubMedCrossRef
26.
go back to reference Hajj Hussein I, Chams N, Chams S, El Sayegh S, Badran R, Raad M, et al. Vaccines through centuries: major cornerstones of global health. Front Public Health. 2015;3:269.PubMedPubMedCentralCrossRef Hajj Hussein I, Chams N, Chams S, El Sayegh S, Badran R, Raad M, et al. Vaccines through centuries: major cornerstones of global health. Front Public Health. 2015;3:269.PubMedPubMedCentralCrossRef
27.
go back to reference Prasad NK, Lake R, Englum BR, Turner DJ, Siddiqui T, Mayorga-Carlin M, et al. COVID-19 vaccination associated with reduced postoperative SARS-CoV-2 infection and morbidity. Ann Surg. 2022;275(1):31.PubMedCrossRef Prasad NK, Lake R, Englum BR, Turner DJ, Siddiqui T, Mayorga-Carlin M, et al. COVID-19 vaccination associated with reduced postoperative SARS-CoV-2 infection and morbidity. Ann Surg. 2022;275(1):31.PubMedCrossRef
28.
go back to reference Pinato DJ, Ferrante D, Aguilar-Company J, Bower M, Salazar R, Mirallas O, et al. Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer. Eur J Cancer. 2022;171:64–74.PubMedPubMedCentralCrossRef Pinato DJ, Ferrante D, Aguilar-Company J, Bower M, Salazar R, Mirallas O, et al. Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer. Eur J Cancer. 2022;171:64–74.PubMedPubMedCentralCrossRef
29.
go back to reference Chung JY, Thone MN, Kwon YJ. COVID-19 vaccines: The status and perspectives in delivery points of view. Adv Drug Deliv Rev. 2021;170:1–25.PubMedCrossRef Chung JY, Thone MN, Kwon YJ. COVID-19 vaccines: The status and perspectives in delivery points of view. Adv Drug Deliv Rev. 2021;170:1–25.PubMedCrossRef
30.
go back to reference Reynolds MW, Secora A, Joules A, Albert L, Brinkley E, Kwon T, et al. Evaluating real-world COVID-19 vaccine effectiveness using a test-negative case–control design. J Comp Eff Res. 2022;11(16):1161–72.PubMedCrossRef Reynolds MW, Secora A, Joules A, Albert L, Brinkley E, Kwon T, et al. Evaluating real-world COVID-19 vaccine effectiveness using a test-negative case–control design. J Comp Eff Res. 2022;11(16):1161–72.PubMedCrossRef
31.
go back to reference Liu M, Li Y. Advances in COVID-19 vaccines and new coronavirus variants. Front Med. 2022;9:1–10. Liu M, Li Y. Advances in COVID-19 vaccines and new coronavirus variants. Front Med. 2022;9:1–10.
32.
go back to reference Fajar JK, Sallam M, Soegiarto G, Sugiri YJ, Anshory M, Wulandari L, et al. Global Prevalence and Potential Influencing Factors of COVID-19 Vaccination Hesitancy: A Meta-Analysis. Vaccines. 2022;10(8):1356.PubMedPubMedCentralCrossRef Fajar JK, Sallam M, Soegiarto G, Sugiri YJ, Anshory M, Wulandari L, et al. Global Prevalence and Potential Influencing Factors of COVID-19 Vaccination Hesitancy: A Meta-Analysis. Vaccines. 2022;10(8):1356.PubMedPubMedCentralCrossRef
33.
go back to reference Wafula ST, Mugume IB, Sensasi B, Okware S, Chimbaru A, Nanyunja M, et al. Intention to vaccinate against COVID-19 and adherence to non-pharmaceutical interventions against COVID-19 prior to the second wave of the pandemic in Uganda: a cross-sectional study. BMJ Open. 2022;12(6):e057322.PubMedCrossRef Wafula ST, Mugume IB, Sensasi B, Okware S, Chimbaru A, Nanyunja M, et al. Intention to vaccinate against COVID-19 and adherence to non-pharmaceutical interventions against COVID-19 prior to the second wave of the pandemic in Uganda: a cross-sectional study. BMJ Open. 2022;12(6):e057322.PubMedCrossRef
37.
go back to reference Plans-Rubió P. Vaccination coverage for routine vaccines and herd immunity levels against measles and pertussis in the world in 2019. Vaccines. 2021;9(3):256.PubMedPubMedCentralCrossRef Plans-Rubió P. Vaccination coverage for routine vaccines and herd immunity levels against measles and pertussis in the world in 2019. Vaccines. 2021;9(3):256.PubMedPubMedCentralCrossRef
38.
go back to reference Afolabi AA, Ilesanmi OS. Dealing with vaccine hesitancy in Africa: the prospective COVID-19 vaccine context. Pan Afr Med J. 2021;38:1–7.CrossRef Afolabi AA, Ilesanmi OS. Dealing with vaccine hesitancy in Africa: the prospective COVID-19 vaccine context. Pan Afr Med J. 2021;38:1–7.CrossRef
39.
go back to reference Acheampong T, Akorsikumah EA, Osae-Kwapong J, Khalid M, Appiah A, Amuasi JH. Examining vaccine Hesitancy in Sub-Saharan Africa: a survey of the knowledge and attitudes among adults to receive COVID-19 vaccines in Ghana. Vaccines. 2021;9(8):814.PubMedPubMedCentralCrossRef Acheampong T, Akorsikumah EA, Osae-Kwapong J, Khalid M, Appiah A, Amuasi JH. Examining vaccine Hesitancy in Sub-Saharan Africa: a survey of the knowledge and attitudes among adults to receive COVID-19 vaccines in Ghana. Vaccines. 2021;9(8):814.PubMedPubMedCentralCrossRef
40.
go back to reference Dinga JN, Njoh AA, Gamua SD, Muki SE, Titanji VP. Factors driving COVID-19 Vaccine hesitancy in Cameroon and their implications for Africa: A comparison of two cross-sectional studies conducted 19 months apart in 2020 and 2022. Vaccines. 2022;10(9):1401.PubMedPubMedCentralCrossRef Dinga JN, Njoh AA, Gamua SD, Muki SE, Titanji VP. Factors driving COVID-19 Vaccine hesitancy in Cameroon and their implications for Africa: A comparison of two cross-sectional studies conducted 19 months apart in 2020 and 2022. Vaccines. 2022;10(9):1401.PubMedPubMedCentralCrossRef
41.
go back to reference Ouni PD, Namulondo R, Wanume B, Okia D, Olupot PO, Nantale R, et al. COVID-19 vaccine hesitancy among health workers in rural Uganda: A mixed methods study. Vaccine: X. 2023;13:100260. Ouni PD, Namulondo R, Wanume B, Okia D, Olupot PO, Nantale R, et al. COVID-19 vaccine hesitancy among health workers in rural Uganda: A mixed methods study. Vaccine: X. 2023;13:100260.
42.
go back to reference Ackah BB, Woo M, Stallwood L, Fazal ZA, Okpani A, Ukah UV, et al. COVID-19 vaccine hesitancy in Africa: a scoping review. Global Health Res Policy. 2022;7(1):1–20.CrossRef Ackah BB, Woo M, Stallwood L, Fazal ZA, Okpani A, Ukah UV, et al. COVID-19 vaccine hesitancy in Africa: a scoping review. Global Health Res Policy. 2022;7(1):1–20.CrossRef
43.
go back to reference Bongomin F, Olum R, Andia-Biraro I, Nakwagala FN, Hassan KH, Nassozi DR, et al. COVID-19 vaccine acceptance among high-risk populations in Uganda. Ther Adv Infect Dis. 2021;8:20499361211024376.PubMedPubMedCentral Bongomin F, Olum R, Andia-Biraro I, Nakwagala FN, Hassan KH, Nassozi DR, et al. COVID-19 vaccine acceptance among high-risk populations in Uganda. Ther Adv Infect Dis. 2021;8:20499361211024376.PubMedPubMedCentral
44.
go back to reference Calina D, Docea AO, Petrakis D, Egorov AM, Ishmukhametov AA, Gabibov AG, et al. Towards effective COVID-19 vaccines: updates, perspectives and challenges (Review). Int J Mol Med. 2020;46(1):3–16.PubMedPubMedCentralCrossRef Calina D, Docea AO, Petrakis D, Egorov AM, Ishmukhametov AA, Gabibov AG, et al. Towards effective COVID-19 vaccines: updates, perspectives and challenges (Review). Int J Mol Med. 2020;46(1):3–16.PubMedPubMedCentralCrossRef
45.
go back to reference Jennings W, Stoker G, Bunting H, Valgarðsson VO, Gaskell J, Devine D, et al. Lack of trust, conspiracy beliefs, and social media use predict COVID-19 vaccine hesitancy. Vaccines. 2021;9(6):593.PubMedPubMedCentralCrossRef Jennings W, Stoker G, Bunting H, Valgarðsson VO, Gaskell J, Devine D, et al. Lack of trust, conspiracy beliefs, and social media use predict COVID-19 vaccine hesitancy. Vaccines. 2021;9(6):593.PubMedPubMedCentralCrossRef
46.
go back to reference Bright B, Babalola CP, Sam-Agudu NA, Onyeaghala AA, Olatunji A, Aduh U, et al. COVID-19 preparedness: capacity to manufacture vaccines, therapeutics and diagnostics in sub-Saharan Africa. Glob Health. 2021;17(1):24.CrossRef Bright B, Babalola CP, Sam-Agudu NA, Onyeaghala AA, Olatunji A, Aduh U, et al. COVID-19 preparedness: capacity to manufacture vaccines, therapeutics and diagnostics in sub-Saharan Africa. Glob Health. 2021;17(1):24.CrossRef
47.
go back to reference Marco-Franco JE, Pita-Barros P, Vivas-Orts D, González-de-Julián S, Vivas-Consuelo D. COVID-19, fake news, and vaccines: should regulation be implemented? Int J Environ Res Public Health. 2021;18(2):744.PubMedPubMedCentralCrossRef Marco-Franco JE, Pita-Barros P, Vivas-Orts D, González-de-Julián S, Vivas-Consuelo D. COVID-19, fake news, and vaccines: should regulation be implemented? Int J Environ Res Public Health. 2021;18(2):744.PubMedPubMedCentralCrossRef
49.
go back to reference WHO. Strategic Advisory Group of Experts on Immunization (SAGE). 2022. WHO. Strategic Advisory Group of Experts on Immunization (SAGE). 2022.
50.
go back to reference Nawas GT, Zeidan RS, Edwards CA, El-Desoky RH. Barriers to COVID-19 Vaccines and Strategies to Improve Acceptability and Uptake. J Pharm Pract. 2022;36(4):08971900221081621. Nawas GT, Zeidan RS, Edwards CA, El-Desoky RH. Barriers to COVID-19 Vaccines and Strategies to Improve Acceptability and Uptake. J Pharm Pract. 2022;36(4):08971900221081621.
51.
54.
go back to reference Mohammed R, Nguse TM, Habte BM, Fentie AM, Gebretekle GB. COVID-19 vaccine hesitancy among Ethiopian healthcare workers. PloS One. 2021;16(12):e0261125.PubMedPubMedCentralCrossRef Mohammed R, Nguse TM, Habte BM, Fentie AM, Gebretekle GB. COVID-19 vaccine hesitancy among Ethiopian healthcare workers. PloS One. 2021;16(12):e0261125.PubMedPubMedCentralCrossRef
55.
go back to reference Danabal KGM, Magesh SS, Saravanan S, Gopichandran V. Attitude towards COVID 19 vaccines and vaccine hesitancy in urban and rural communities in Tamil Nadu, India – a community based survey. BMC Health Serv Res. 2021;21(1):994.PubMedPubMedCentralCrossRef Danabal KGM, Magesh SS, Saravanan S, Gopichandran V. Attitude towards COVID 19 vaccines and vaccine hesitancy in urban and rural communities in Tamil Nadu, India – a community based survey. BMC Health Serv Res. 2021;21(1):994.PubMedPubMedCentralCrossRef
56.
go back to reference Bain N, Nguyen M, Grech L, Day D, McCartney A, Webber K, et al. COVID-19 vaccine hesitancy in Australian patients with solid organ cancers. Vaccines. 2022;10(9):1373.PubMedPubMedCentralCrossRef Bain N, Nguyen M, Grech L, Day D, McCartney A, Webber K, et al. COVID-19 vaccine hesitancy in Australian patients with solid organ cancers. Vaccines. 2022;10(9):1373.PubMedPubMedCentralCrossRef
57.
go back to reference Scoccimarro D, Panichi L, Ragghianti B, Silverii A, Mannucci E, Monami M. Sars-CoV2 vaccine hesitancy in Italy: a survey on subjects with diabetes. Nutr Metab Cardiovasc Dis. 2021;31(11):3243–6.PubMedPubMedCentralCrossRef Scoccimarro D, Panichi L, Ragghianti B, Silverii A, Mannucci E, Monami M. Sars-CoV2 vaccine hesitancy in Italy: a survey on subjects with diabetes. Nutr Metab Cardiovasc Dis. 2021;31(11):3243–6.PubMedPubMedCentralCrossRef
58.
go back to reference Asadi-Pooya AA, Barzegar Z, Sadeghian S, Nezafat A, Shahisavandi M, Nabavizadeh SA. COVID-19 vaccine hesitancy among patients with epilepsy or other chronic conditions. Disast Med Public Health Prepared. 2022;16(5):1848–50.CrossRef Asadi-Pooya AA, Barzegar Z, Sadeghian S, Nezafat A, Shahisavandi M, Nabavizadeh SA. COVID-19 vaccine hesitancy among patients with epilepsy or other chronic conditions. Disast Med Public Health Prepared. 2022;16(5):1848–50.CrossRef
60.
go back to reference Wong LP, Alias H, Wong P-F, Lee HY, AbuBakar S. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Hum Vacc Immunother. 2020;16(9):2204–14.CrossRef Wong LP, Alias H, Wong P-F, Lee HY, AbuBakar S. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Hum Vacc Immunother. 2020;16(9):2204–14.CrossRef
61.
go back to reference Cambon L, Schwarzinger M, Alla F. Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: a challenge for one of the world’s most vaccine-hesitant countries. Vaccine. 2022;40(2):178–82.PubMedCrossRef Cambon L, Schwarzinger M, Alla F. Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: a challenge for one of the world’s most vaccine-hesitant countries. Vaccine. 2022;40(2):178–82.PubMedCrossRef
62.
go back to reference Yeşiltepe A, Aslan S, Bulbuloglu S. Investigation of perceived fear of COVID-19 and vaccine hesitancy in nursing students. Hum Vacc Immunother. 2021;17(12):5030–7.CrossRef Yeşiltepe A, Aslan S, Bulbuloglu S. Investigation of perceived fear of COVID-19 and vaccine hesitancy in nursing students. Hum Vacc Immunother. 2021;17(12):5030–7.CrossRef
63.
go back to reference Yehualashet DE, Seboka BT, Tesfa GA, Mamo TT, Yawo MN, Hailegebreal S. Prevalence and determinants of COVID-19 vaccine hesitancy among the Ethiopian population: a systematic review. Risk Manag Healthc Policy. 2022;15:1433–45.PubMedPubMedCentralCrossRef Yehualashet DE, Seboka BT, Tesfa GA, Mamo TT, Yawo MN, Hailegebreal S. Prevalence and determinants of COVID-19 vaccine hesitancy among the Ethiopian population: a systematic review. Risk Manag Healthc Policy. 2022;15:1433–45.PubMedPubMedCentralCrossRef
64.
65.
go back to reference Zaidi A, Elmasaad A, Alobaidli H, Sayed R, Al-Ali D, Al-Kuwari D, et al. Attitudes and Intentions toward COVID-19 vaccination among Health professions students and faculty in Qatar. Vaccines. 2021;9(11):1275.PubMedPubMedCentralCrossRef Zaidi A, Elmasaad A, Alobaidli H, Sayed R, Al-Ali D, Al-Kuwari D, et al. Attitudes and Intentions toward COVID-19 vaccination among Health professions students and faculty in Qatar. Vaccines. 2021;9(11):1275.PubMedPubMedCentralCrossRef
66.
go back to reference Savoia E, Harriman NW, Piltch-Loeb R, Bonetti M, Toffolutti V, Testa MA. Exploring the association between misinformation endorsement, opinions on the government response, risk perception, and COVID-19 vaccine hesitancy in the US, Canada, and Italy. Vaccines. 2022;10(5):671.PubMedPubMedCentralCrossRef Savoia E, Harriman NW, Piltch-Loeb R, Bonetti M, Toffolutti V, Testa MA. Exploring the association between misinformation endorsement, opinions on the government response, risk perception, and COVID-19 vaccine hesitancy in the US, Canada, and Italy. Vaccines. 2022;10(5):671.PubMedPubMedCentralCrossRef
67.
go back to reference Kobayashi T, Nishina Y, Tomoi H, Harada K, Matsumoto E, Inaba K, et al. 439. Corowa-kun: Impact of a COVID-19 Vaccine Information Chatbot on Vaccine Hesitancy, Japan 2021. Open Forum Infect Dis. 2021;8(Supplement_1):S321-S2. Kobayashi T, Nishina Y, Tomoi H, Harada K, Matsumoto E, Inaba K, et al. 439. Corowa-kun: Impact of a COVID-19 Vaccine Information Chatbot on Vaccine Hesitancy, Japan 2021. Open Forum Infect Dis. 2021;8(Supplement_1):S321-S2.
68.
go back to reference Bates BR, Villegas-Botero A, Costales JA, Moncayo AL, Tami A, Carvajal A, et al. COVID-19 vaccine hesitancy in three Latin American countries: reasons given for not becoming vaccinated in Colombia, Ecuador, and Venezuela. Health Commun. 2022;37(12):1465–75.PubMedCrossRef Bates BR, Villegas-Botero A, Costales JA, Moncayo AL, Tami A, Carvajal A, et al. COVID-19 vaccine hesitancy in three Latin American countries: reasons given for not becoming vaccinated in Colombia, Ecuador, and Venezuela. Health Commun. 2022;37(12):1465–75.PubMedCrossRef
69.
go back to reference McElfish PA, Willis DE, Shah SK, Bryant-Moore K, Rojo MO, Selig JP. Sociodemographic determinants of COVID-19 vaccine hesitancy, fear of infection, and protection self-efficacy. J Prim Care Commun Health. 2021;12:21501327211040744.CrossRef McElfish PA, Willis DE, Shah SK, Bryant-Moore K, Rojo MO, Selig JP. Sociodemographic determinants of COVID-19 vaccine hesitancy, fear of infection, and protection self-efficacy. J Prim Care Commun Health. 2021;12:21501327211040744.CrossRef
70.
go back to reference Ouyang H, Ma X, Wu X. The prevalence and determinants of COVID-19 vaccine hesitancy in the age of infodemic. Hum Vacc Immunother. 2022;18(1):2013694.CrossRef Ouyang H, Ma X, Wu X. The prevalence and determinants of COVID-19 vaccine hesitancy in the age of infodemic. Hum Vacc Immunother. 2022;18(1):2013694.CrossRef
71.
73.
go back to reference Syed Alwi S, Rafidah E, Zurraini A, Juslina O, Brohi IB, Lukas S. A survey on COVID-19 vaccine acceptance and concern among Malaysians. BMC Public Health. 2021;21(1):1129.PubMedPubMedCentralCrossRef Syed Alwi S, Rafidah E, Zurraini A, Juslina O, Brohi IB, Lukas S. A survey on COVID-19 vaccine acceptance and concern among Malaysians. BMC Public Health. 2021;21(1):1129.PubMedPubMedCentralCrossRef
74.
go back to reference Qunaibi E, Basheti I, Soudy M, Sultan I. Hesitancy of Arab healthcare workers towards COVID-19 vaccination: a large-scale multinational study. Vaccines. 2021;9(5):446.PubMedPubMedCentralCrossRef Qunaibi E, Basheti I, Soudy M, Sultan I. Hesitancy of Arab healthcare workers towards COVID-19 vaccination: a large-scale multinational study. Vaccines. 2021;9(5):446.PubMedPubMedCentralCrossRef
Metadata
Title
COVID-19 vaccine hesitancy: assessing the prevalence, predictors, and effectiveness of a community pharmacy based counseling intervention
Authors
Joshua Kiptoo
John Isiiko
Tadele Mekuriya Yadesa
Tumugumye Rhodah
Paul E. Alele
Edgar Mugema Mulogo
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-023-17532-4

Other articles of this Issue 1/2024

BMC Public Health 1/2024 Go to the issue